Global Clinical Trial

This study covers the world outlook for ePRO, e-patient diaries and eCOA across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr ...

Global Clinical Data Analytics Market to Reach US$193.1 Billion by 2030 The global market for Clinical Data Analytics estimated at US$39.1 Billion in the year 2024, is expected to reach US$193.1 Billion by 2030, growing at a CAGR of 30.5% over the analysis period 2024-2030. Quality Care, one of the ...

Global Regulatory Affairs Outsourcing Market to Reach US$9.2 Billion by 2030 The global market for Regulatory Affairs Outsourcing estimated at US$5.6 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Regulatory Submis ...

Global Biosimulation Technology Market to Reach US$8.5 Billion by 2030 The global market for Biosimulation Technology estimated at US$3.6 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 15.6% over the analysis period 2024-2030. Software, one of the segment ...

Global Electronic Data Capture Market to Reach US$2.7 Billion by 2030 The global market for Electronic Data Capture estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 13.6% over the analysis period 2024-2030. Services, one of the segments ...

Global Acute Myeloid Leukemia (AML) Therapeutics Market to Reach US$1.7 Billion by 2030 The global market for Acute Myeloid Leukemia (AML) Therapeutics estimated at US$785.7 Million in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 202 ...

Global Clinical Trial Management Systems (CTMS) Market to Reach US$4.5 Billion by 2030 The global market for Clinical Trial Management Systems (CTMS) estimated at US$2.0 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2024-20 ...

Global Peripheral Arterial Disease (PAD) Therapeutics Market to Reach US$7.8 Billion by 2030 The global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis per ...

Global e-Clinical Trial Technologies Market to Reach US$31.1 Billion by 2030 The global market for e-Clinical Trial Technologies estimated at US$14.8 Billion in the year 2024, is expected to reach US$31.1 Billion by 2030, growing at a CAGR of 13.1% over the analysis period 2024-2030. Clinical Trial ...

Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025 provides an overview of Kidney Disease (Nephropathy) Clinical trials scenario. This report provides top line data relatin ...

Alopecia Universalis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Alopecia Universalis - Global Clinical Trials Review, 2025 provides an overview of Alopecia Universalis Clinical trials scenario. This report provides top line data relating to the clinical trials ...

Vertigo - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Vertigo - Global Clinical Trials Review, 2025 provides an overview of Vertigo Clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes an overvie ...

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2025 provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Cl ...

Migraine - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Migraine - Global Clinical Trials Review, 2025 provides an overview of Migraine Clinical trials scenario. This report provides top line data relating to the clinical trials on Migraine. Report includes an ove ...

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2025 provides an overview of Muscle Invasive Bladder Cancer (MIBC) Clinical trials scenario. This report pro ...

Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2025 provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data rela ...

Sickle Cell Disease - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Sickle Cell Disease - Global Clinical Trials Review, 2025 provides an overview of Sickle Cell Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ...

Endometriosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Endometriosis - Global Clinical Trials Review, 2025 provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Re ...

Hypoglycemia - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Hypoglycemia - Global Clinical Trials Review, 2025 provides an overview of Hypoglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypoglycemia. Report ...

In Vivo CRO Market Size and Growth The global in Vivo CRO market size was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 13.74 billion by 2033, growing at a CAGR of 8.34% from 2024 to 2033. In Vivo CRO Market Key Takeaways In 2023, the rodent based segment dominated the ma ...

The global Cell And Gene Therapy CDMO market size was estimated at USD 5.90 billion in 2023 and is projected to hit around USD 69.11 billion by 2033, growing at a CAGR of 27.9% during the forecast period from 2024 to 2033. Key Takeaways: North America accounts for the largest share of 40.18% in 2023 ...

The electronic clinical outcome assessment (eCOA) solutions market is projected to reach USD 4.78 billion by 2030 from USD 2.27 billion in 2025, at a CAGR of 16.1% during the forecast period. The growing inclination towards digital data collection and analysis, an escalating need for economic data c ...

Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025" - provides an overview of Neuropathic Pain (Neuralgia) Clinical trials scenario. This report provides top line data rela ...

Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025" - provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top li ...

Seasonal Influenza - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2025" - provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on ...